Patent · US Active

Enrichment of mutated cell free nucleic acids for cancer detection

US11624064B2 · kind B2 · utility

0Cited by
5References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 13, 2017
Grant dateApr 11, 2023
Priority date
Expiry dateApr 23, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein are methods of enriching mutated cell free nucleic acids for detection and diagnosis of cancer. Also provided are methods using a CRISPR-Cas system to target and deplete unwanted more abundant cell free nucleic acid sequences thereby enriching for less abundant sequences.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.